New research reveals the critical actions needed to ensure COVID-19-driven surge in virtual health and care drives health access and equity
- COVID-19 pandemic triggered a massive surge in virtual health and care delivery across the world, with many countries embracing hybrid virtual and in-person services
- Report from the Broadband Commission for Sustainable Development Working Group on Virtual Health and Care – co-chaired by the World Health Organization and the Novartis Foundation – provides learnings from 23 countries
- The report calls on health decision makers to act to prevent digital divides from increasing health inequities: countries need to implement clear policies that ensure equitable and inclusive access to virtual services for entire populations
Basel, June 16, 2022 — Many unnecessary restrictions on virtual health and care were swept away by the pandemic, and most people have embraced this new world of virtual care, according to a new report from a Broadband Commission on Sustainable Development working group. The Future of Health and Care – driving access and equity through inclusive policies details how the past two years have changed access to health and care in 23 countries as diverse as Rwanda, Singapore and the United States.
Virtual health solutions are those that seek to keep people healthy; care solutions treat those who are already sick. The use of both surged during the pandemic. In the U.S., the percentage of telehealth claims out of all health claims was 25 times higher in January 2022 compared to October 2019. In India, the numbers of synchronous teleconsultations on the national teleconsultation and e-outpatient service e-Sanjeevani were four times higher in February 2022 than in October 2020.
“In the past two years, I have seen transformations in health and care delivery that I thought would take at least a decade,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus, who co-chaired the Working Group on Virtual Health and Care, which developed the report. “We have seen that decision makers are now embracing hybrid health systems that combine virtual and in-person services. This is an incredible advance in healthcare, one that was long overdue and is now happening at an accelerated pace due to the pandemic. But countries need to introduce careful policies to ensure their entire populations can benefit from these changes.”
The use of virtual health and care is popular: surveys conducted in the U.S. in 2021 show that over three-quarters of patients want virtual services to be a continuing part of their care and that over 80% of providers intend to continue using virtual health after the COVID-19 pandemic has eased. But many countries have not yet developed coherent frameworks to ensure virtual health services work effectively alongside in-person care.
The report includes an analysis of virtual health and care policies in 23 countries. These insights form the foundation for a comprehensive roadmap that provides practical actions to help countries ensure virtual health and care drives health access and equity. Policymakers need to make sure their health systems are fully integrating virtual services, to support inclusive and equitable access for all.
“As we emerge from the pandemic, there is a clear momentum for policymakers around the globe to build on to further digitize health and care delivery,” said Dr Ann Aerts of the Novartis Foundation and Working Group Co-Chair. “To ensure this rollout is done in a way that builds equitable access to health and care, it is essential to combine virtual and in-person health service delivery. As some population groups may have less access to mobile phones and internet or lower levels of digital literacy, countries have to ensure inclusive and equitable policy making to further integrate virtual services into their overall health systems. People who need help to access or navigate virtual health services, for example, require targeted attention.”
The report notes that for some groups, internet access can be an issue, although this is changing rapidly. Data security and patient privacy are other areas that need attention from policymakers.
“For people to benefit from virtual health and care, equal access to digital connectivity is essential. Worldwide, women have less access than men,” said Ms Doreen Bogdan-Martin, Executive Director of the Broadband Commission and Director of the ITU Telecommunication Development Bureau. “The latest ITU data clearly illustrates that the gender digital divide in internet use remains wide, and is most persistent in the least developed countries, where only 19% of women use the internet. We must continue to work together to ensure that access to digital health is universal.”
About the Novartis Foundation
The Novartis Foundation is a non-profit organization based in Switzerland. For over 40 years, we have helped improve the health of low-income populations, initially supporting disease elimination in areas such as leprosy and malaria. Today, we tackle the burning issues of our time, cardiovascular diseases and health inequity. We take a population health approach, which means bringing together existing but disconnected data to help authorities understand the root causes of unequal health outcomes, and define the best ways and best partners to remediate those. This empowers governments to transform their health systems from being reactive to proactive, predictive and preventative, and achieve health equity among the populations they serve.
The Novartis Foundation is on Twitter at @NovartisFDN
About the Broadband Commission for Sustainable Development
Since 2010, The ITU/UNESCO Broadband Commission for Sustainable Development has leveraged the strength of its cross-sectoral membership and collective expertise to advocate for meaningful, universal connectivity. This report is the fourth in a series published by the Commission’s Working Groups on health, which aim to define how data, AI and digital health can contribute to the realization of the health-related Sustainable Development Goals. The current Working Group on Virtual Health and Care is co-chaired by the World Health Organization and the Novartis Foundation and has more than 35 world experts in ICT and health as members. The report was developed with support from Accenture.
Novartis Foundation Media Relations
Contact: Carolyn Canham
Tel: +41 79 334 4325
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Huhtamaki publishes 2022 Half-yearly Report on July 21, 202230.6.2022 09:00:00 CEST | Press release
HUHTAMÄKI OYJ PRESS RELEASE 30.6.2022 AT 10:00 Huhtamaki publishes 2022 Half-yearly Reporton July21, 2022 Huhtamäki Oyj will publish its 2022 Half-yearly Report on Thursday, July 21, 2022, approximately at 8.30 am Finnish time (EEST). The release and related results presentation material will be available after publishing at www.huhtamaki.com/investors. Teleconference Huhtamaki will arrange a combined audiocast and teleconference on the same day at 9.30 am Finnish time, where the company’s management will present the results. The event will be followed by a Q&A session. The event will be held in English, it can be followed real-time at: https://huhtamaki.videosync.fi/2022-q2 If you wish to ask questions, please dial one of the following numbers 5-10 minutes prior to the call start: Finland Toll: +358981710310 Sweden Toll: +46 856642651 United Kingdom Toll: +44 3333000804 United States Toll: +1 6319131422 Confirmation code for the call is 23337170# An on-demand replay of the audiocast w
Fingerprints announces design win for its optical under-display solution with major Asian smartphone OEM30.6.2022 08:00:00 CEST | Press release
Fingerprint Cards AB (Fingerprints™) today announced that it has secured a design win* for its optical under-display solution, FPC 1632, with a major Asian smartphone OEM, following successful qualification tests earlier this year. We expect to commence shipments during the fourth quarter of 2022. “Since many years, Fingerprints is a well-established world leader in capacitive fingerprint sensors. The design win we are announcing today marks our entry into a new market segment: optical under-display fingerprint sensors. This will open up attractive new growth opportunities for us going forward, and our goal is to capture a significant share of this market,” says Ted Hansson, President Mobile, PC & Access China at Fingerprints. For more information about Fingerprints’ mobile device solutions, visit the website. * Fingerprints’ definition of Design Win (DW): The decision by a device vendor (OEM or ODM) to start development of one or several commercial product(s) incorporating Fingerprint
Inaugural Yara Clean Ammonia Capital Markets Day30.6.2022 08:00:00 CEST | Press release
Oslo, 30 June 2022: Today, Yara International ASA (“Yara”) will host a Capital Markets Day (“CMD”) for Yara Clean Ammonia (“YCA” or the “Company”). During the event, members of YCA’s management team will present key features of the Company, including its strategy and growth ambitions, as well as financial parameters and targets for the future. In May 2022, Yara announced that it is evaluating a potential initial public offering (“IPO”) of YCA on the Oslo Stock Exchange. “While the decision to list YCA will be made in due course, Yara is now excited to host an inaugural CMD for YCA to showcase their exciting story,” said Svein Tore Holsether, CEO and President of Yara. “YCA combines a leading midstream business with exceptional growth prospects and a value creating project portfolio.” Key highlights: Clean ammonia represents a massive opportunity that is projected to drive exponential, long-term market growth .YCA comprises existing cash flows from a market leading position  in a
Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial of UV1 in Malignant Melanoma30.6.2022 08:00:00 CEST | Press release
Full recruitment of 154 patients with malignant melanoma in U.S. and Europe in 24 monthsStudy provides randomized data on impact of UV1 on standard-of-care immunotherapy Topline progression-free survival data expected H1 2023 Oslo, 30 June 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announces the completed recruitment of 154 patients in the INITIUM trial. INITIUM is Ultimovacs’ Phase II clinical trial of its universal cancer vaccine UV1 in combination with the checkpoint inhibitors ipilimumab and nivolumab in metastatic malignant melanoma. Consistent with INITIUM’s event-driven design, topline progression-free survival results will be disclosed after progression of cancer or death has been observed in a total of 70 patients. “It is a remarkable achievement that Ultimovacs and its clinical partners have completed recruitment to INITIUM largely on schedule despite challenges caused by the pandemic,” said Carlos de Sou
Sampo plc’s share buybacks 29/06/202230.6.2022 07:30:00 CEST | Press release
SAMPO PLC STOCK EXCHANGE RELEASE 30/06/2022 at 08:30 am Sampo plc’s share buybacks 29/06/2022 On 29/06/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code)14,37741.79AQEU49,88741.79CEUX8,78241.76TQEX102,19541.79XHELTOTAL175,24141.79 *rounded to two decimals On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based on the authorization granted by Sampo's Annual General Meeting on 18 May 2022. After the disclosed transactions, the company owns in total 2,017,160 Sampo A shares representing 0.38 per cent of the total number of shares in Sampo plc. Details of e